Ozempic is manufactured by Novo Nordisk, a Danish pharmaceutical company that was founded in 1923 and is the biggest pharmaceutical company in all of Denmark
Multiple perspectives are considered including the viewpoints of researchers (e.g
50 This modest effect was not associated with adverse cardiovascular outcomes in any of the major clinical trials
Key factors include: the drug shortages have been resolved (tirzepatide in October 2024, semaglutide in February 2025), FDA-approved versions are commercially available, and the agency has received over 775 adverse event reports linked to compounded versions, many involving dosing errors from multi-dose vials
Interventions were frequently administered for 12 weeks, and the strains commonly included Lactobacillus acidophilus/casei/rhamnosus, Bifidobacterium bifidum/longum/breve, and Streptococcus thermophilus, with nearly all randomized controlled trials incorporating Lactobacillus acidophilus in their probiotics [179]